Skip to main content

Table 2 Patients complications up to 30 days after surgery

From: Postoperative outcomes in surgical COVID-19 patients: a multicenter cohort study

Variables COVID-19 patients
(n = 44)
Symptomatic
(n = 26)
Asymptomatic
(n = 18)
Complications
 Pulmonary complications 11 (25%) 9 (35%) 2 (11%)
 Infectious complications (non-pulmonary) 4 (9%) 1 (4%) 3 (17%)
 Acute kidney injurya 8 (18%) 4 (15%) 4 (22%)
 Thromboembolic complications 2 (5%) 2 (8%) 0 (0%)
Resource utilization
 New ICU admissions 12 (27%) 10 (39%) 2 (11%)
 Hospital length of stay 17 [4, 36] 22 [6, 40] 7 [3, 22]
 Mechanical ventilation free days (at 30 days) 27.0 (7.4) 25.0 (9.1) 29.9 (0.3)
 Organ dysfunction-free days (at 30 days) 25.2 (9.3) 22.2 (11.1) 29.6 (1.4)
Mortality
 30-day mortality 7 (15.9%) 6 (23.1%) 1 (5.6%)
 Kaplan-Meir survival probabilityb 0.84 [0.74, 0.96] 0.77 [0.62, 0.95] 0.94 [0.84, 1.00]
  1. Data is reported as mean (SD), as median [q1, q3] or as number of events (proportion in %)
  2. Abbreviations: ICU Intensive care unit
  3. a No acute kidney injury required renal replacement therapy
  4. b 30-day survival probability from the estimated Kaplan-Meir survival function, expressed with 95% confidence intervals